Medical Oncologist

Contact Information
5841 S Maryland Ave
Mc 2115
Chicago, IL 60637
Phone: (773) 702-4150

Specialty & Clinical Interests
Medical Oncologist: Genitourinary Medical

Hospital Affiliation
University of Chicago Medical Center
Ranked #31 in Cancer

Education & Medical Training
Michael Reese Hospital and Medical Center
Residency, Internal Medicine, 1988 - 1991
University of Chicago
Fellowship, Hematology, 1991 - 1994
Yale University School of Medicine
Class of 1988

Certifications & Licensure
American Board of Internal Medicine
Certified 22 years in Internal Medicine
American Board of Internal Medicine
Certified 20 years in Medical Oncology
IL State Medical License
Active through 2014

Awards, Honors & Recognition
ACP Fellow, American College of Physicians
2002

Publications & Presentations
The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate-resistant prostate cancer: Results from a retrospective analysis of a randomized phase 3 clinical trial (CALGB 90401) (
Aggarwal, R.,Halabi, S.,Kelly, W. K.,George, D.,Mahoney, J. F.,Millard, F.,Stadler, W. M.,Morris, M. J.,Kantoff, P.,Monk, J. P.,Carducci, M.,Small, E. J.
Axitinib in metastatic renal cell carcinoma: results of a pharmacokinetic and pharmacodynamic analysis.
Rini, B. I.,Garrett, M.,Poland, B.,Dutcher, J. P.,Rixe, O.,Wilding, G.,Stadler, W. M.,Pithavala, Y. K.,Kim, S.,Tarazi, J.,Motzer, R. J.
Estimation of renal cell carcinoma treatment effects from disease progression modeling.
Maitland, M. L.,Wu, K.,Sharma, M. R.,Jin, Y.,Kang, S. P.,Stadler, W. M.,Karrison, T. G.,Ratain, M. J.,Bies, R. R.